UPDATED May 31, 2024
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
6055 | HK$13.68 | 11.2% | 44.6% | HK$9.5b | HK$14.33 | PE15.8x | E8.3% | 2.3% | Retail | ||
2411 | HK$3.14 | 3.3% | -44.4% | HK$5.0b | HK$3.97 | PE12.8x | E7.5% | 1.5% | Consumer Retailing | ||
816 | HK$2.56 | -3.0% | -26.6% | HK$2.3b | HK$2.25 | PE6.4x | E12.4% | 6.6% | Real Estate Management and Development | ||
2877 | HK$8.36 | -6.7% | -2.5% | HK$6.3b | HK$14.05 | PE6x | E14.5% | 6.9% | Pharmaceuticals & Biotech | ||
2192 | HK$7.60 | -0.4% | 5.3% | HK$5.5b | HK$10.09 | PE21.1x | E-7.2% | 3.5% | Healthcare | ||
2172 | HK$9.12 | 1.3% | -32.6% | HK$5.3b | HK$14.01 | PE33.8x | E31.7% | 1.2% | Healthcare |